» Articles » PMID: 1764030

Inhibition of Gluconeogenesis in Isolated Rat Hepatocytes After Chronic Treatment with Phenobarbital

Overview
Journal Biochem J
Specialty Biochemistry
Date 1991 Dec 15
PMID 1764030
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Gluconeogenesis was studied in hepatocytes isolated from phenobarbital-pretreated rats fasted for 24 h. In closed vial incubations, glucose production from lactate (20 mmol/l) and pyruvate (2 mmol/l), alanine (20 mmol/l) or glutamine (20 mmol/l) was suppressed by about 30-45%, although glycerol metabolism was not affected. In hepatocytes perifused with lactate and pyruvate (ratio 10:1), glucose production was inhibited by 50%, even at low gluconeogenic flux. From the determination of gluconeogenic intermediates at several steady states of gluconeogenic flux, we have found a single relationship between phosphoenolpyruvate and the rate of glucose production (Jglucose), and two different curves between cytosolic oxaloacetate and Jglucose in controls and in phenobarbital-pretreated hepatocytes. By using 3-mercaptopicolinate to determine the flux control coefficient of phosphoenolpyruvate carboxykinase we found that phenobarbital pretreatment led to an increase in this coefficient from 0.3 (controls) to 0.8 (phenobarbital group). These observations were confirmed by the finding that the activity of phosphoenolpyruvate carboxykinase was decreased by 50% after phenobarbital treatment. Hence we conclude that the inhibitory effect of phenobarbital on gluconeogenesis is due, at least partly, to a decrease in the flux through phosphoenolpyruvate carboxykinase.

Citing Articles

Clinical Relevance of the Constitutive Androstane Receptor.

Stern S, Kurian R, Wang H Drug Metab Dispos. 2022; 50(7):1010-1018.

PMID: 35236665 PMC: 11022901. DOI: 10.1124/dmd.121.000483.


Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis.

Dempsey J, Wang D, Siginir G, Fei Q, Raftery D, Gu H Toxicol Sci. 2018; 168(1):40-60.

PMID: 30407581 PMC: 6821357. DOI: 10.1093/toxsci/kfy271.


Targeting xenobiotic receptors PXR and CAR in human diseases.

Banerjee M, Robbins D, Chen T Drug Discov Today. 2014; 20(5):618-28.

PMID: 25463033 PMC: 4433851. DOI: 10.1016/j.drudis.2014.11.011.


Targeting xenobiotic receptors PXR and CAR for metabolic diseases.

Gao J, Xie W Trends Pharmacol Sci. 2012; 33(10):552-8.

PMID: 22889594 PMC: 3461088. DOI: 10.1016/j.tips.2012.07.003.


Post-translational modification of pregnane x receptor.

Staudinger J, Xu C, Biswas A, Mani S Pharmacol Res. 2011; 64(1):4-10.

PMID: 21397695 PMC: 3111031. DOI: 10.1016/j.phrs.2011.02.011.


References
1.
Lahtela J, Sarkka P, Sotaniemi E . Phenobarbital treatment enhances insulin mediated glucose metabolism in man. Res Commun Chem Pathol Pharmacol. 1984; 44(2):215-26. View

2.
Kida K, Nishio T, Yokozawa T, Nagai K, Matsuda H, Nakagawa H . The circadian change of gluconeogenesis in the liver in vivo in fed rats. J Biochem. 1980; 88(4):1009-13. DOI: 10.1093/oxfordjournals.jbchem.a133051. View

3.
Groen A, Sips H, Vervoorn R, Tager J . Intracellular compartmentation and control of alanine metabolism in rat liver parenchymal cells. Eur J Biochem. 1982; 122(1):87-93. DOI: 10.1111/j.1432-1033.1982.tb05851.x. View

4.
Groen A, Vervoorn R, van der Meer R, Tager J . Control of gluconeogenesis in rat liver cells. I. Kinetics of the individual enzymes and the effect of glucagon. J Biol Chem. 1983; 258(23):14346-53. View

5.
Sotaniemi E, Stengard J, Saarni H, Arranto A, Keinanen K, Kerola T . Hepatic glucose-6-phosphatase activity in non-insulin dependent diabetics. Effect of enzyme-inducing drugs. Acta Med Scand. 1984; 215(4):323-31. DOI: 10.1111/j.0954-6820.1984.tb05014.x. View